Figure 2.1

Distribution of point prevalent general Medicare (age 65 & older) & MarketScan (age 50–64) patients with coded diabetes, CKD, CHF, & CVA, 2009
[Download]

Figure 2.2

Prevalence of recognized CKD, by census region & dataset
[Download]

Figure 2.3

Trends in CKD prevalence: Medicare patients age 65 & older, by race
[Download]

Figure 2.4

Trends in CKD prevalence: MarketScan patients age 20–64
[Download]

Figure 2.5

Trends in CKD prevalence: Ingenix i3 patients age 20–64
[Download]

Figure 2.6

Probability of microalbumin & creatinine testing in Medicare patients at risk for CKD
[Download]

Figure 2.7

Odds ratio of a CKD diagnosis code in Medicare patients age 65 & older, by age, gender, & race, 2009
[Download]

Figure 2.8

Odds ratio of a CKD diagnosis code in MarketScan patients age 50–64, by age & gender, 2009
[Download]

Figure 2.9

Odds ratio of a CKD diagnosis code in Medicare & MarketScan patients, by comorbidity, 2009
[Download]

Figure 2.10

Cumulative probability of a physician visit at month 12 following CKD diagnosis in 2008, by physician specialty & dataset
[Download]

Figure 2.11

Hazard ratio of Medicare patients seeing a nephrologist 12 months after CKD diagnosis in 2008, by age, gender, & race
[Download]

Figure 2.12

Hazard ratio of MarketScan patients seeing a nephrologist 12 months after CKD diagnosis in 2008, by age & gender
[Download]

Figure 2.13

Hazard ratio of patients seeing a nephrologist 12 months after CKD diagnosis in 2008, by comorbidity, CKD stage, & dataset
[Download]

Figure 2.14

Medicare Part D & MarketScan CKD patients with at least one claim for an ACEI/ARB/renin inhibitor in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.15

Medicare Part D & MarketScan CKD patients with at least one claim for a beta blocker in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.16

Medicare Part D & MarketScan CKD patients with at least one claim for a DHP calcium channel blocker in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.17

Medicare Part D & MarketScan CKD patients with at least one claim for a lipid lowering agent in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.18

Medicare Part D & MarketScan CKD patients with at least one claim for a diuretic in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.19

Medicare Part D & MarketScan CKD patients with at least one claim for an ESA in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.20

Medicare Part D & MarketScan CKD patients with at least one claim for oral vitamin D in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Figure 2.21

Medicare Part D & MarketScan CKD patients with at least one claim for a phosphate binder in the 12 months following the disease-defining entry period, by CKD diagnosis code, 2008
[Download]

Table A

Descriptive parameters of CKD datasets, by age, gender, race, ethnicity, & coded comorbidity
[Download]

Table B

Prevalence (%) of recognized CKD, by dataset, year, & age
[Download]

Table C

Probability of laboratory testing in patients at risk for CKD, by demographic characteristics, 2009
[Download]

Table D

Percent of patients with CKD, by demographic characteristics, comorbidity, & dataset, 2009
[Download]

Table E

Percent of patients with CKD of Stage 3 or higher, by demographic characteristics, comorbidity, & dataset, 2009
[Download]

Table F

Adjusted odds ratio of a CKD diagnosis code, by demographic characteristics, comorbidity, & dataset, 2009
[Download]

Table G

Cumulative probability of a physician visit at month 12 after CKD diagnosis in 2008, by demographic characteristics, physician specialty, & dataset
[Download]

Table H

Cumulative probability of a physician visit at month 12 after a CKD diagnosis code of 585.3 or higher in 2008, by demographic characteristics, physician specialty, & dataset
[Download]

Table I

Hazard ratio of seeing a nephrologist 12 months after CKD diagnosis in 2008, by demographics, comorbidity, CKD stage, & dataset
[Download]